0 followers
Shoreline's proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced metabolic fitness and persistence of the engineered NK Cells to improve anti-cancer activity.
Kleanthis G. Xanthopoulos
Tessera Therapeutics
2 followers
Pyxis Oncology
2 followers
Brightseed
2 followers
Obsidian Therapeutics
1 follower
Apogee Therapeutics
1 follower
Cargo
1 follower
Cue Biopharma
1 follower
Anthos Therapeutics
1 follower
Kyverna Therapeutics
7 followers
Generate Biomedicines
3 followers
Strand Therapeutics
3 followers
Explore companies